Edwards Larry Todd 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jan 17, 2024
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Award
Common Stock
2024-01-12+28,000→ 88,000 total - Award
Stock Option (right to buy)
2024-01-12+176,000→ 176,000 totalExercise: $3.64Exp: 2034-01-12→ Common Stock (176,000 underlying)
Footnotes (2)
- [F1]Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.